Research graph
References from Analysis of immune subtypes across the epithelial-mesenchymal plasticity spectrum. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1002/1878-0261.12083
10.1002/1878-0261.12083 · External reference
10.1016/j.cell.2016.06.028
10.1016/j.cell.2016.06.028 · External reference
10.1038/s41580-020-0237-9
10.1038/s41580-020-0237-9 · External reference
10.1007/s00441-016-2464-0
10.1007/s00441-016-2464-0 · External reference
10.1083/jcb.201506014
10.1083/jcb.201506014 · External reference
10.1128/mcb.00373-16
10.1128/mcb.00373-16 · External reference
10.1371/journal.pone.0076773
10.1371/journal.pone.0076773 · External reference
MicroRNAs as regulators of epithelial-mesenchymal transition
10.4161/cc.7.20.6851 · 2008 · External reference
The microRNA-200 family regulates epithelial to mesenchymal transition
10.1100/tsw.2008.115 · 2008 · External reference
The splicing regulators Esrp1 and Esrp2 direct an epithelial splicing program essential for mammalian development.
2015 · External reference
Interconnected feedback loops among ESRP1, HAS2, and CD44 regulate epithelial-mesenchymal plasticity in cancer
10.1063/1.5024874 · 2018 · External reference
10.1016/j.molcel.2009.01.025
10.1016/j.molcel.2009.01.025 · External reference
Epithelial-to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular Plasticity
10.1016/j.tig.2017.08.004 · 2017 · External reference
Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications
10.1186/s12943-016-0502-x · 2016 · External reference
Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells
10.1093/carcin/bgn216 · 2008 · External reference
10.1038/s41598-017-15139-5
10.1038/s41598-017-15139-5 · External reference
10.3390/biom9080339
10.3390/biom9080339 · External reference
10.1038/ncb1691
10.1038/ncb1691 · External reference
Stromal fibroblasts from the interface zone of human breast carcinomas induce an epithelial-mesenchymal transition-like state in breast cancer cells in vitro
10.1242/jcs.072900 · 2010 · External reference
10.1158/0008-5472.can-10-0785
10.1158/0008-5472.can-10-0785 · External reference
10.1038/s41467-018-05992-x
10.1038/s41467-018-05992-x · External reference
Cancer-associated fibroblast-derived SDF-1 induces epithelial-mesenchymal transition of lung adenocarcinoma via CXCR4/β-catenin/PPARδ signalling
10.1038/s41419-021-03509-x · 2021 · External reference
Permissive State of EMT: The Role of Immune Cell Compartment
10.3389/fonc.2020.00587 · 2020 · External reference
The Vicious Cross-Talk between Tumor Cells with an EMT Phenotype and Cells of the Immune System
10.3390/cells8050460 · 2019 · External reference
10.1371/journal.pbio.1001162
10.1371/journal.pbio.1001162 · External reference
10.1038/s41556-019-0309-2
10.1038/s41556-019-0309-2 · External reference
10.1016/j.ccr.2012.10.012
10.1016/j.ccr.2012.10.012 · External reference
10.1016/j.celrep.2013.11.014
10.1016/j.celrep.2013.11.014 · External reference
10.1016/j.ccr.2012.09.022
10.1016/j.ccr.2012.09.022 · External reference
EMT programs promote basal mammary stem cell and tumor-initiating cell stemness by inducing primary ciliogenesis and Hedgehog signaling
2017 · External reference
Cancer stem-like side population cells in the human nasopharyngeal carcinoma cell line cne-2 possess epithelial mesenchymal transition properties in association with metastasis
2012 · External reference
IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation
10.1186/1476-4598-11-87 · 2012 · External reference
Hybrid E/M Phenotype(s) and Stemness: A Mechanistic Connection Embedded in Network Topology
2020 · External reference
10.1038/ncb1998
10.1038/ncb1998 · External reference
10.1038/nature15748
10.1038/nature15748 · External reference
10.1038/nature16064
10.1038/nature16064 · External reference
10.1126/science.1228522
10.1126/science.1228522 · External reference
10.1088/1478-3975/aaf7b7
10.1088/1478-3975/aaf7b7 · External reference
10.1038/nrc3265
10.1038/nrc3265 · External reference
10.1158/0008-5472.can-16-3521
10.1158/0008-5472.can-16-3521 · External reference
Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers
10.1158/1541-7786.mcr-10-0490 · 2011 · External reference
10.1186/s40425-018-0382-2
10.1186/s40425-018-0382-2 · External reference
10.1158/1078-0432.ccr-18-1550
10.1158/1078-0432.ccr-18-1550 · External reference
The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)
10.1186/s40425-019-0813-8 · 2019 · External reference
10.1158/0008-5472.can-10-2217
10.1158/0008-5472.can-10-2217 · External reference
10.1038/s41467-018-03966-7
10.1038/s41467-018-03966-7 · External reference
NKG2D ligand RAE1ε induces generation and enhances the inhibitor function of myeloid-derived suppressor cells in mice
10.1111/jcmm.13124 · 2017 · External reference
10.1016/j.humpath.2016.07.007
10.1016/j.humpath.2016.07.007 · External reference
10.1038/ncomms6241
10.1038/ncomms6241 · External reference
10.1158/0008-5472.can-16-3292
10.1158/0008-5472.can-16-3292 · External reference
10.1016/j.canlet.2019.10.013
10.1016/j.canlet.2019.10.013 · External reference
Immunoregulatory molecule B7–H1 (CD274) contributes to skin carcinogenesis
10.1158/0008-5472.can-11-0527 · 2011 · External reference
Zeb1 induces immune checkpoints to form an immunosuppressive envelope around invading cancer cells. Science
2021 · External reference
10.1016/j.imlet.2021.05.004
10.1016/j.imlet.2021.05.004 · External reference
10.1038/nature10166
10.1038/nature10166 · External reference
Unresolved reference
External reference
10.1186/s13059-017-1349-1
10.1186/s13059-017-1349-1 · External reference
10.1007/978-1-4939-7493-1_12
10.1007/978-1-4939-7493-1_12 · External reference
CRI iAtlas: an interactive portal for immuno-oncology research
10.12688/f1000research.25141.1 · 2020 · External reference
Comparative Study of Transcriptomics-Based Scoring Metrics for the Epithelial-Hybrid-Mesenchymal Spectrum
10.3389/fbioe.2020.00220 · 2020 · External reference
10.1016/j.immuni.2018.03.023
10.1016/j.immuni.2018.03.023 · External reference
Interrogation of Phenotypic Plasticity between Epithelial and Mesenchymal States in Breast Cancer
2019 · External reference
Morphological State Transition Dynamics in EGF-Induced Epithelial to Mesenchymal Transition
2019 · External reference
10.1039/c5ib00219b
10.1039/c5ib00219b · External reference
10.1016/j.cell.2017.10.044
10.1016/j.cell.2017.10.044 · External reference
10.1038/onc.2015.444
10.1038/onc.2015.444 · External reference
10.1158/0008-5472.can-14-2535
10.1158/0008-5472.can-14-2535 · External reference
10.1371/journal.pcbi.1007619
10.1371/journal.pcbi.1007619 · External reference
10.1158/1078-0432.ccr-12-1558
10.1158/1078-0432.ccr-12-1558 · External reference
10.15252/emmm.201404208
10.15252/emmm.201404208 · External reference
10.1038/ncomms9971
10.1038/ncomms9971 · External reference
ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance
10.3389/fmolb.2020.00036 · 2020 · External reference
Unresolved reference
2021 · External reference
SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions
10.1093/nar/gki965 · 2005 · External reference
10.1016/j.cell.2004.06.006
10.1016/j.cell.2004.06.006 · External reference
10.1158/0008-5472.can-11-4038
10.1158/0008-5472.can-11-4038 · External reference
10.18632/oncotarget.13682
10.18632/oncotarget.13682 · External reference
10.1038/oncsis.2017.87
10.1038/oncsis.2017.87 · External reference
Unresolved reference
2020 · External reference
10.1002/jcb.25974
10.1002/jcb.25974 · External reference
10.1016/j.tig.2010.11.002
10.1016/j.tig.2010.11.002 · External reference
Identifying inhibitors of epithelial-mesenchymal plasticity using a network topology-based approach
10.1038/s41540-020-0132-1 · 2020 · External reference
Hysteresis control of epithelial-mesenchymal transition dynamics conveys a distinct program with enhanced metastatic ability
10.1038/s41467-018-07538-7 · 2018 · External reference
10.4161/rna.6.5.9606
10.4161/rna.6.5.9606 · External reference
Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via different mechanisms
10.1074/jbc.m114.589432 · 2014 · External reference
Systems-level network modeling deciphers the master regulators of phenotypic plasticity and heterogeneity in melanoma
2021 · External reference
10.7554/elife.64522.sa2
10.7554/elife.64522.sa2 · External reference
10.1002/1878-0261.12093
10.1002/1878-0261.12093 · External reference
Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome
10.1073/pnas.1521812113 · 2016 · External reference
Single sample scoring of molecular phenotypes
10.1186/s12859-018-2435-4 · 2018 · External reference
Functional Hierarchy and Cooperation of EMT Master Transcription Factors in Breast Cancer Metastasis
10.1158/1541-7786.mcr-20-0532 · 2021 · External reference
Unresolved reference
2019 · External reference
10.3390/cancers11081213
10.3390/cancers11081213 · External reference
B7–H3, a checkpoint molecule, as a target for cancer immunotherapy
10.7150/ijbs.41105 · 2020 · External reference
10.1038/nm.3931
10.1038/nm.3931 · External reference
Molecular and immune correlates of TIM-3 (HAVCR2) and galectin 9 (LGALS9) mRNA expression and DNA methylation in melanoma. In Clinical
2019 · External reference
10.1371/journal.pcbi.1004569
10.1371/journal.pcbi.1004569 · External reference
10.18632/oncotarget.8166
10.18632/oncotarget.8166 · External reference
Transcriptional mechanisms link epithelial plasticity to adhesion and differentiation of epidermal progenitor cells
10.1016/j.devcel.2014.03.005 · 2014 · External reference
Cell state plasticity, stem cells, EMT, and the generation of intra-tumoral heterogeneity
10.1038/s41523-017-0012-z · 2017 · External reference
A specific lipid metabolic profile is associated with the epithelial mesenchymal transition program
10.1016/j.bbalip.2018.12.011 · 2019 · External reference
Multi-Omic Regulation of the PAM50 Gene Signature in Breast Cancer Molecular Subtypes
10.3389/fonc.2020.00845 · 2020 · External reference
10.1016/j.cell.2012.02.008
10.1016/j.cell.2012.02.008 · External reference
10.1016/j.cell.2008.03.027
10.1016/j.cell.2008.03.027 · External reference
Unresolved reference
2015 · External reference
An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition
10.1091/mbc.e11-02-0103 · 2011 · External reference
A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer
10.1038/onc.2011.540 · 2012 · External reference
10.1038/onc.2015.497
10.1038/onc.2015.497 · External reference
10.1126/scitranslmed.aad7118
10.1126/scitranslmed.aad7118 · External reference
TIM-3 is expressed in melanoma cells and is upregulated in TGF-beta stimulated mast cells
10.1038/sj.jid.5700616 · 2007 · External reference
10.1136/gutjnl-2014-307671
10.1136/gutjnl-2014-307671 · External reference
Galectin-9 promotes TGF-β1-dependent induction of regulatory T cells via the TGF-β/Smad signaling pathway
10.3892/mmr.2012.1125 · 2013 · External reference
10.1016/j.immuni.2014.06.011
10.1016/j.immuni.2014.06.011 · External reference
10.1371/journal.pone.0078644
10.1371/journal.pone.0078644 · External reference
10.1038/nature08460
10.1038/nature08460 · External reference
